Etid klinik pou Dyabèt nan Kansas
4 etid pou Dyabèt ap chèche patisipan nan sit nan Kansas.
Vil nan Kansas
Tèks ofisyèl etid la (Anglè)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Kansas Nephrology Physicians, PA, Wichita
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Newton
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
- Kansas Nephrology Research Institute, Wichita
Ap rekrite
Laj 18 a 84 · Tout sèks · Mizajou Apr 13, 2026 · NCT06190717Mitigating the Pro-inflammatory Phenotype of Obesity
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 1
Laj 18 a 79 · Tout sèks · Mizajou Jun 5, 2025 · NCT04934228Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.